Hélène Asnagli

Hélène has more than 20 years of experience in non-clinical R&D, mainly in auto-immune diseases, in various environments ranging from small to well recognized large biotechs in Europe and the US (Step Pharma, TxCell (now part of Sangamo Therapeutics), Serono, Anosys, Celmed BioSciences). Hélène has worked on a broad spectrum of programs including cell-based therapies, monoclonal antibodies, and small molecules.

Hélène is an immunologist by training with a PhD obtained at the Center of immunology CNRS-Inserm in Marseille which she conducted a post-doctoral fellowship at Washington University, St Louis, USA.